Human Immunoglobulin (pH4) for Intravenous Injection Market, By Type (IgG, IgA, and IgM), By Disease Indication (COVID-19, Primary Immunodeficiency Disease, Immune-mediated Thrombocytopenia, Kawasaki Disease, B Chronic lymphocytic Leukemia(B-CLL), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
Select a License Type that Suits your Business Needs
Excel Databook
US$ 2,200
Two thousand two hundred dollars
Single User License
( Full Report )
US$ 4,500
US$ 3,500
Three thousand five hundred dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
US$ 5,500
Five thousand five hundred dollars
Corporate User License
( Full Report )
US$ 10,000
US$ 7500
Seven thousand five hundred dollars
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients